Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;44(4):289-299.
doi: 10.1159/000449511. Epub 2016 Sep 15.

Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts

Affiliations

Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts

Hanni Menn-Josephy et al. Am J Nephrol. 2016.

Abstract

Background: The extent of interstitial fibrosis on kidney biopsy is regarded as a prognostic indicator and guide to treatment. Patients with extensive fibrosis are assigned to supportive treatments with the expectation that they have advanced beyond the point at which immunosuppressive or other disease-modifying therapies would be of benefit. Our study highlights some of the limitations of using interstitial fibrosis to predict who will develop end-stage renal disease (ESRD).

Methods: Analysis of 434 consecutive renal biopsies performed between 2001 and 2012 at a single center. We assessed the influence of various clinical factors along with fibrosis as predictors of ESRD and dialysis-free survival in various patient groups.

Results: Interstitial fibrosis performed well overall as a predictor of progression to dialysis. On average, patients with >50% fibrosis progressed more rapidly than those with either 25-49 or 0-24% fibrosis with a median time to dialysis of 1.2, 6.5 and >10 years, respectively. In contrast, interstitial fibrosis was of less value as a predictor of disease progression in a subset of cases that included patients over the age of 70 and those with diabetic nephropathy on biopsy. Surprisingly, 13.9% of patients with normal renal function had 25-49% fibrosis and 5% had more than 50% fibrosis on biopsy, and 5 years after undergoing biopsy 21% of patients with >50% fibrosis still remained dialysis free.

Conclusion: Renal fibrosis is an imperfect prognostic indicator for the development of ESRD and caution should be exercised in applying it too rigidly, especially in elderly or diabetic patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Correlation between GFR and degree of fibrosis
A. Percentage of fibrosis according to GFR levels. B. A scatter plot of the overall cohort mapping the association of GFR with percent fibrosis. Each dot represents a single patient. (GFR, Glomerular Filtration Rate).
Figure 2
Figure 2. Dialysis prediction model
Parsimonious prediction model for reaching dialysis. See Methods for a detailed description of the prediction model development. 2A: Dialysis prediction model using 6 variables: parsimonious 0.2 level (left panel) and receiver operator curve for 6 variable model predicting dialysis (right panel) (variables included: BMI, percentage of interstitial fibrosis, creatinine, proteinuria, HTN, IDDM). (AUC, area under the curve; BMI, Body Mass Index; GFR, Glomerular Filtration Rate; HTN, hypertension; IDDM, insulin dependent diabetes; CAD, coronary artery disease; DM, diabetes mellitus; IgA, Immunoglobulin A; DM, diabetes mellitus; IgA, Immunoglobulin A). 2B. Interstitial fibrosis alone dialysis prediction model (left panel) and receiver operator curve (ROC) for dialysis prediction model using interstitial fibrosis only.
Fig 3
Fig 3
Kaplan-Meier analysis of time-to-dialysis according to the level of interstitial fibrosis.
Fig 4
Fig 4. Correlation between fibrosis and time to dialysis
A scatter plot of the overall cohort mapping the association of percentage fibrosis and time to dialysis. Each dot represents a single patient.

Comment in

References

    1. Kostadinova-Kunovska S, Petrusevska G, Jovanovic R, Grcevska L, Bogdanovska M, Polenakovic M. Morphological changes in the tubulointerstitial compartment in primary glomerulopathies. Prilozi. 2007;28:61–74. - PubMed
    1. Madaio MP. Renal biopsy. Kidney international. 1990;38:529–543. - PubMed
    1. Seron D, Moreso F, Fulladosa X, Hueso M, Carrera M, Grinyo JM. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney international. 2002;61:727–733. - PubMed
    1. Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, Manns B, Hemmelgarn B. Histopathologic features aid in predicting risk for progression of iga nephropathy. Clinical journal of the American Society of Nephrology : CJASN. 2010;5:425–430. - PMC - PubMed
    1. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis. 1992;20:1–17. - PubMed

Publication types

MeSH terms